查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1929560

透析試劑盒市場：依材料、透析方法、定價模式、最終用戶和銷售管道，全球預測，2026-2032年

Dialysis Kits Market by Material, Modality, Pricing Model, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年透析試劑盒市值為 3.3321 億美元，預計到 2026 年將成長至 3.5923 億美元，預計到 2032 年將達到 5.2584 億美元，複合年成長率為 6.73%。

關鍵市場統計數據
基準年 2025 3.3321億美元
預計年份：2026年 3.5923億美元
預測年份 2032 5.2584億美元
複合年成長率 (%) 6.73%

在複雜的醫療環境中，透析試劑盒市場應兼顧臨床績效、籌資策略、法規遵循和營運彈性。

隨著人口結構變化、慢性病流行以及醫療服務模式創新等因素共同重塑臨床需求和採購重點，透析試劑盒市場環境正面臨日益嚴峻的策略挑戰。臨床醫生和供應鏈管理人員越來越關注如何在不同醫療環境中平衡成本壓力和營運實際情況，同時確保產品品質穩定、符合監管要求並確保患者安全。因此，相關人員正在尋求能夠將臨床績效指標與籌資策略和營運可行性連結起來的分析。

產品設計創新、分散式醫療服務模式以及日益嚴格的監管正在重新定義供應商選擇和籌資策略

在技​​術進步、醫療模式變革和相關人員期望不斷變化的影響下，醫療產業正經歷著一場變革性的轉變。試劑盒設計和材料的創新提高了易用性和感染控制水平，使得更多操作能夠在門診和家庭環境中安全地進行。同時，醫療服務模式正變得更加分散化，更加重視門診中心和居家醫療，這就要求試劑盒必須高度便攜、易於使用，並相容於遠距臨床監測。

評估 2025 年美國關稅如何影響透析試劑盒供應鏈的供應風險放大、採購調整和策略採購決策。

由於美國將於2025年實施一系列關稅，透析試劑盒相關人員面臨供應鏈複雜性和成本的累積挑戰。關稅帶來的成本壓力正在影響上游原料分銷和零件進口，迫使採購團隊重新評估籌資策略和庫存管理政策。因此，各組織正在權衡短期成本增加與採購多元化、近岸外包和加強供應商合作等策略優勢。

詳細的細分分析重點在於治療方式、終端使用者環境、材料、分銷管道和定價策略對採購和臨床整合的影響。

關鍵的細分分析表明，治療方法、最終用戶、材料組合、銷售管道和定價模式均對採購決策和臨床工作流程產生不同的影響。在基於治療方法的分類中，血液透析試劑盒、血液淨化試劑盒和腹膜透析試劑盒之間的差異不僅決定了其與治療通訊協定的臨床相容性，還決定了組件組裝的複雜性和滅菌要求。因此，臨床團隊在考慮不同治療方式的表現特徵以及物流要求的同時，也需要考慮這些因素，以確保其能無縫地融入治療流程。

區域觀點：美洲、歐洲、中東和非洲以及亞太地區趨勢對透析試劑盒監管、採購和應用的影響

區域趨勢對透析試劑盒產業的法規結構、供應鏈結構和臨床應用模式有顯著影響。在美洲，採購和臨床路徑反映了醫療支付模式的多樣性以及對擴大門診和居家照護的日益重視，從而推動了對便捷性、安全性和遠端監測功能更優的試劑盒的需求。該地區的相關人員往往優先考慮供應商的可靠性和合約履約保證，以確保患者照護的連續性。

產業競爭洞察：產品差異化、垂直整合、服務生態系統與供應鏈策略如何重塑公司定位

製造商和供應商之間的競爭正圍繞著四大策略支柱：透過臨床性能實現產品差異化、組件採購的垂直整合、服務和支援生態系統以及供應鏈韌性。主要企業正投資於提升安全性、易用性和設備相容性的設計特性，同時也在完善品管體系，以加快監管核准並保持產品在不同地區的一致性。這種對差異化的關注正推動企業與醫療機構建立合作關係，以檢驗產品在實際應用中的表現，並加速臨床醫生對產品的接受度。

加強透析試劑盒採購韌性、臨床協作、設計創新和服務主導差異化的實用建議

為了獲得策略優勢，產業領導者應採取一系列合作措施，將臨床價值與商業性韌性結合。首先，應優先考慮關鍵零件的供應商多元化和雙重採購策略，以減輕關稅和地緣政治動盪的影響。透過在合約條款中加入價格調整條款、庫存保留協議以及針對替代供應商的快速資格認證流程，來強化合約。其次，應使採購規範與臨床團隊保持一致，確保產品選擇既能滿足病患安全需求，又能兼顧營運限制。這將減少實施過程中的摩擦，並避免因不相容造成的廢棄物。

解釋如何運用混合調查方法（結合專家訪談、監管分析和供應鏈情境檢驗）得出可操作的產業結論

本分析的研究結合了定性專家直接對話和定量營運及監管數據整合，以確保獲得可靠且可操作的見解。關鍵資料來源包括對醫院採購主管、各科室臨床醫生、供應鏈經理和高級產品開發主管的結構化訪談，以收集有關績效重點、採購限制和實施障礙的第一手資訊。這些第一手資訊與監管指南、材料安全標準和行業最佳實踐等第二手資料進行三角驗證，從而更好地理解營運影響。

最終的綜合分析將臨床、採購和供應鏈的優先事項提煉為可操作的策略重點領域，以穩定透析供應並改善患者照護。

總之，透析試劑盒市場格局是由臨床需求、籌資策略和供應鏈實際情況的交互作用所決定。決策者必須仔細考慮不同透析方式的具體要求、終端用戶的差異、材料的權衡取捨、分銷管道和定價模式，才能提供安全高效的透析服務。關稅趨勢和區域差異進一步增加了採購決策的複雜性，但同時也為透過靈活的採購策略、設計創新和服務型交付實現策略差異化創造了機會。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依材料分類的透析試劑盒市場

  • 聚乙烯
  • PVC

9. 依透析方式分類的透析試劑盒市場

  • 血液透析套裝
  • 血液灌流套件
  • 腹膜透析套裝

第10章 透析試劑盒市場定價模式

  • 免洗工具包
  • 可重複使用套裝

第11章 以最終用戶分類的透析設備市場

  • 門診手術中心
  • 透析中心
  • 居家醫療
  • 醫院

第12章 透析試劑盒市場銷售管道

  • 直銷
  • 經銷合作夥伴
  • 線上

第13章 各地區透析設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 透析設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國透析設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國透析設備市場

第17章 中國透析設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allmed Medical GmbH
  • AngioDynamics, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Atlantic Biomedical Pvt. Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bellco Srl
  • Dialife SA
  • Farmasol
  • Fresenius Medical Care AG & Co. KGaA
  • Guangdong Kanghua Healthcare Co., Ltd.
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Mar Cor Purification, Inc.
  • Medline Industries, Inc.
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • NxStage Medical, Inc.
  • Outset Medical, Inc.
  • Pall Corporation
  • Poly Medicure Limited
  • Rockwell Medical, Inc.
  • Teleflex Incorporated
  • Thermo Fisher Scientific Inc.
  • Toray Medical Co., Ltd.
  • Zhejiang Asia-Pacific Pharmaceutical Co., Ltd.
Product Code: MRR-0A380695181B

The Dialysis Kits Market was valued at USD 333.21 million in 2025 and is projected to grow to USD 359.23 million in 2026, with a CAGR of 6.73%, reaching USD 525.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 333.21 million
Estimated Year [2026] USD 359.23 million
Forecast Year [2032] USD 525.84 million
CAGR (%) 6.73%

Framing the dialysis kits landscape to align clinical performance, procurement strategy, regulatory compliance, and operational resilience in complex care environments

The dialysis kits landscape is undergoing a period of heightened strategic importance as demographic trends, chronic disease prevalence, and care-delivery innovations converge to reshape clinical demand and procurement priorities. Clinicians and supply chain managers are increasingly focused on ensuring consistent product quality, regulatory compliance, and patient safety while balancing cost pressures and the operational realities of diverse care settings. As a result, stakeholders require analyses that bridge clinical performance characteristics with sourcing strategies and operational feasibility.

This introduction establishes the foundational context needed to navigate that complexity. It synthesizes how modality choices interact with end-user requirements and how materials and sales approaches influence both cost structures and logistical footprints. Furthermore, it highlights the imperative to align clinical protocols with supplier selection and inventory management so that care continuity and patient outcomes remain paramount. By framing the discussion around these interdependent factors, this section prepares decision-makers to weigh trade-offs, prioritize investments, and identify the levers that will most effectively drive quality, resilience, and efficiency across dialysis kit programs.

How innovations in product design, decentralization of care delivery, and heightened regulatory focus are redefining supplier selection and procurement strategies

The industry is experiencing transformative shifts driven by technological advances, changing care models, and evolving stakeholder expectations. Innovations in kit design and materials have improved usability and infection control, enabling more procedures to be safely performed in outpatient and home-based settings. Simultaneously, care delivery is decentralizing, with greater emphasis on ambulatory centers and home healthcare, which requires kits that are portable, simple to use, and compatible with remote clinical oversight.

In parallel, procurement strategies are moving beyond short-term cost metrics toward total-cost-of-care thinking, where lifecycle considerations, sterilization protocols, and compatibility with existing equipment shape supplier relationships. Regulatory scrutiny is intensifying around device traceability and biocompatibility, prompting manufacturers to invest in compliance infrastructure and quality systems. Together, these forces are accelerating product differentiation and encouraging collaboration between clinical, commercial, and supply chain teams to co-develop solutions that meet evolving clinical pathways and patient-centric delivery models.

Assessing how 2025 tariff measures in the United States have amplified supply chain risk, procurement adaptation, and strategic sourcing decisions across dialysis kit ecosystems

The cumulative impact of recent tariff actions in the United States during 2025 has introduced measurable supply chain complexity and cost considerations for dialysis kit stakeholders. Tariff-induced cost pressures have affected upstream raw material flows and component imports, prompting procurement teams to reassess sourcing strategies and inventory policies. As a result, organizations are balancing short-term cost increases against the strategic benefits of diversified sourcing, nearshoring, and strengthened supplier partnerships.

Operational responses have included a re-evaluation of vendor contracts, increased emphasis on supplier visibility, and expedited qualification of alternative manufacturers to mitigate single-source exposures. Clinically, buyers are prioritizing continuity of supply and product equivalence to avoid disruptions to patient care. From a strategic standpoint, tariff uncertainty has acted as a catalyst for investments in supply chain mapping and risk modeling, encouraging stakeholders to quantify vulnerability across supplier tiers and to pursue contractual terms that share risk more equitably. Ultimately, the tariff environment has reinforced the need for supply chain agility, robust contingency planning, and more collaborative commercial relationships between providers and kit manufacturers.

Deep segmentation analysis revealing how modality, end-user setting, materials, distribution channels, and pricing approaches shape procurement and clinical integration

Key segmentation insights reveal how modality, end-user, material composition, sales channel, and pricing model each exert distinct influences on procurement decisions and clinical workflows. Based on modality, distinctions among Hemodialysis Kits, Hemoperfusion Kits, and Peritoneal Dialysis Kits determine not only clinical compatibility with treatment protocols but also the complexity of component assemblies and sterilization needs. Consequently, clinical teams weigh modality-specific performance characteristics alongside logistical requirements to ensure seamless integration within care pathways.

Based on end user, the needs of Ambulatory Surgical Centers diverge from those of Dialysis Centers, Home Healthcare programs, and Hospitals, with each setting prioritizing factors such as kit portability, ease of use, and supply redundancy differently. Based on material, selection between Polyethylene and PVC impacts both biocompatibility considerations and environmental disposal practices, which in turn influence procurement specifications and sustainability commitments. Based on sales channel, the choice between Direct Sales, Distribution Partners, and Online procurement affects lead times, price negotiation leverage, and post-sale service expectations. Finally, based on pricing model, the preference for Disposable Kits versus Reusable Kits shapes inventory policies, sterilization protocols, and long-term cost-of-care calculations. When evaluated together, these segmentation axes guide targeted product development, tailored commercial strategies, and procurement frameworks that align clinical objectives with operational realities.

Comparative regional perspectives highlighting how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence regulation, sourcing, and adoption of dialysis kits

Regional dynamics exert substantial influence on regulatory frameworks, supply chain topology, and clinical adoption patterns in the dialysis kits space. In the Americas, procurement and clinical pathways reflect diverse healthcare payment models and a strong emphasis on outpatient and home-based care expansion, fostering demand for kits optimized for convenience, safety, and remote monitoring compatibility. Stakeholders in this region tend to prioritize supplier reliability and contractual performance commitments that support continuous patient care.

In Europe, Middle East & Africa, regulatory harmonization efforts and heterogeneous healthcare infrastructures create a landscape where compliance, local manufacturing capacity, and distribution networks determine market accessibility. Procurement teams in these territories balance regulatory validation with operational reach to ensure kits meet regional safety standards while remaining logistically feasible. Across Asia-Pacific, rapid adoption of healthcare technologies, investments in local production, and growing emphasis on decentralized care are shaping preferences for cost-effective, scalable kit solutions. Manufacturers and buyers in this region often pursue strategic partnerships to accelerate market entry and to adapt designs to local clinical practices. Collectively, these regional variations inform where manufacturers invest in production, certification, and tailored commercial models to align with local priorities.

Insights into industry competition showing how product differentiation, vertical integration, service ecosystems, and supply chain strategies are reshaping company positioning

Competitive dynamics across manufacturers and suppliers are converging around four strategic pillars: product differentiation through clinical performance, vertical integration of component sourcing, service and support ecosystems, and supply chain resilience. Leading firms are investing in design features that enhance safety, usability, and compatibility with a range of equipment, while simultaneously refining quality systems to expedite regulatory approvals and to maintain product consistency across geographies. This emphasis on differentiation is driving partnerships with clinical institutions to validate real-world performance and to accelerate clinician adoption.

Additionally, several industry players are pursuing vertical integration to secure critical inputs and reduce exposure to tariff-related volatility, enabling more predictable lead times and quality control. Service capabilities-such as training, installation support, and post-sale technical assistance-are increasingly central to commercial value propositions, particularly for ambulatory and home-care segments. At the same time, smaller innovators that focus on niche modalities or materials can exert outsized influence by introducing disruptive assembly methods or sustainable material choices. The result is a marketplace where scale, technical depth, and the ability to provide end-to-end solutions determine competitive advantage and partnership potential.

Actionable recommendations for leaders to strengthen sourcing resilience, clinical alignment, design innovation, and service-led differentiation across dialysis kit programs

Industry leaders should pursue a coordinated set of actions that align clinical value with commercial resilience to capture strategic advantage. First, prioritize supplier diversification and dual-sourcing strategies for critical components to mitigate tariff and geopolitical disruption. Strengthen contractual terms to include clauses for price adjustment, inventory stocking agreements, and accelerated qualification pathways for alternate suppliers. Second, align procurement specifications with clinical teams to ensure product selection reflects both patient safety needs and operational constraints, thereby reducing friction during adoption and limiting waste due to incompatibility.

Third, invest in modular kit design and material innovation to improve usability and to enable rapid adaptation across care settings. Fourth, expand service offerings that accompany product sales-such as training programs, remote monitoring integrations, and localized maintenance-to differentiate on total cost of care rather than unit price alone. Fifth, develop targeted regional strategies that reflect local regulatory landscapes and distribution realities, including consideration for strategic manufacturing footprints and certification roadmaps. By implementing these measures, leaders can enhance resilience, preserve clinical quality, and create defensible commercial positions in an evolving landscape.

Description of the mixed-method research approach combining primary expert interviews, regulatory analysis, and supply chain scenario testing to support actionable industry conclusions

The research underpinning this analysis combines qualitative primary engagement with domain experts and quantitative synthesis of operational and regulatory data to ensure robust, actionable findings. Primary inputs included structured interviews with hospital procurement leaders, clinicians across modalities, supply chain managers, and senior product development executives to capture first-hand perspectives on performance priorities, sourcing constraints, and adoption barriers. These firsthand insights were triangulated with secondary documentation on regulatory guidance, material safety standards, and industry best practices to contextualize operational implications.

Methodological rigor was maintained by cross-validating supplier capability claims against documented certifications and through scenario-based modeling of supply chain disruptions to test resilience measures. Data integrity safeguards included consistency checks, anonymized transcription reviews, and iterative hypothesis testing with subject-matter experts. Limitations of the methodology are acknowledged, including variability in regional procurement practices and the rapid evolution of regulatory interpretations, which necessitate periodic reassessment. Nonetheless, this approach yields a pragmatic synthesis intended to guide actionable decisions and to inform targeted follow-on analyses tailored to specific organizational needs.

Concluding synthesis that distills clinical, procurement, and supply chain priorities into actionable strategic focus areas for improving dialysis kit availability and patient care

In closing, the dialysis kits environment is defined by the interplay between clinical imperatives, procurement strategy, and supply chain realities. Decision-makers must navigate modality-specific requirements, end-user differences, material trade-offs, distribution choices, and pricing models to deliver safe, efficient care. Tariff developments and regional variations further complicate sourcing decisions, but they also create opportunities for strategic differentiation through resilient sourcing, design innovation, and service-based offerings.

Moving from analysis to implementation requires a disciplined approach that aligns clinical teams with procurement, invests in supplier relationships and contingency planning, and prioritizes product features that reduce operational friction. By focusing on these priorities, organizations can protect patient outcomes while achieving more predictable procurement performance. The synthesis provided here is intended to inform executive-level planning and to catalyze targeted initiatives that improve both the quality and continuity of dialysis care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dialysis Kits Market, by Material

  • 8.1. Polyethylene
  • 8.2. PVC

9. Dialysis Kits Market, by Modality

  • 9.1. Hemodialysis Kits
  • 9.2. Hemoperfusion Kits
  • 9.3. Peritoneal Dialysis Kits

10. Dialysis Kits Market, by Pricing Model

  • 10.1. Disposable Kits
  • 10.2. Reusable Kits

11. Dialysis Kits Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Dialysis Centers
  • 11.3. Home Healthcare
  • 11.4. Hospitals

12. Dialysis Kits Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distribution Partners
  • 12.3. Online

13. Dialysis Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Dialysis Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Dialysis Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Dialysis Kits Market

17. China Dialysis Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allmed Medical GmbH
  • 18.6. AngioDynamics, Inc.
  • 18.7. Asahi Kasei Medical Co., Ltd.
  • 18.8. Atlantic Biomedical Pvt. Ltd.
  • 18.9. B. Braun Melsungen AG
  • 18.10. Baxter International Inc.
  • 18.11. Bellco S.r.l.
  • 18.12. Dialife SA
  • 18.13. Farmasol
  • 18.14. Fresenius Medical Care AG & Co. KGaA
  • 18.15. Guangdong Kanghua Healthcare Co., Ltd.
  • 18.16. JMS Co., Ltd.
  • 18.17. Kawasumi Laboratories, Inc.
  • 18.18. Mar Cor Purification, Inc.
  • 18.19. Medline Industries, Inc.
  • 18.20. Nikkiso Co., Ltd.
  • 18.21. Nipro Corporation
  • 18.22. NxStage Medical, Inc.
  • 18.23. Outset Medical, Inc.
  • 18.24. Pall Corporation
  • 18.25. Poly Medicure Limited
  • 18.26. Rockwell Medical, Inc.
  • 18.27. Teleflex Incorporated
  • 18.28. Thermo Fisher Scientific Inc.
  • 18.29. Toray Medical Co., Ltd.
  • 18.30. Zhejiang Asia-Pacific Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIALYSIS KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIALYSIS KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIALYSIS KITS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIALYSIS KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIALYSIS KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIALYSIS KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIALYSIS KITS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIALYSIS KITS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIALYSIS KITS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIALYSIS KITS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIALYSIS KITS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIALYSIS KITS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMODIALYSIS KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMODIALYSIS KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMODIALYSIS KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMOPERFUSION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMOPERFUSION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIALYSIS KITS MARKET SIZE, BY HEMOPERFUSION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIALYSIS KITS MARKET SIZE, BY PERITONEAL DIALYSIS KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIALYSIS KITS MARKET SIZE, BY PERITONEAL DIALYSIS KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIALYSIS KITS MARKET SIZE, BY PERITONEAL DIALYSIS KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISPOSABLE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISPOSABLE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISPOSABLE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIALYSIS KITS MARKET SIZE, BY REUSABLE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIALYSIS KITS MARKET SIZE, BY REUSABLE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIALYSIS KITS MARKET SIZE, BY REUSABLE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIALYSIS KITS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIALYSIS KITS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIALYSIS KITS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIALYSIS KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIALYSIS KITS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIALYSIS KITS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIALYSIS KITS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIALYSIS KITS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIALYSIS KITS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIALYSIS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS DIALYSIS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIALYSIS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. GCC DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. GCC DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 108. GCC DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 109. GCC DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. G7 DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. G7 DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 126. G7 DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 127. G7 DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. G7 DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. NATO DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. NATO DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 132. NATO DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 133. NATO DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NATO DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA DIALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA DIALYSIS KITS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA DIALYSIS KITS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA DIALYSIS KITS MARKET SIZE, BY PRICING MODEL, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA DIALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA DIALYSIS KITS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)